Results 31 to 40 of about 105,631 (265)

Review of Ceftazidime-Avibactam for the Treatment of Infections Caused by Pseudomonas aeruginosa

open access: yesAntibiotics, 2021
Pseudomonas aeruginosa is an opportunistic Gram-negative pathogen that causes a range of serious infections that are often challenging to treat, as this pathogen can express multiple resistance mechanisms, including multidrug-resistant (MDR) and ...
G. Daikos   +6 more
semanticscholar   +1 more source

In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria [PDF]

open access: yes, 2009
Objectives: The goal of the present study was to obtain a comprehensive overview of the bacteriostatic and bactericidal effects of six commonly used antibiotics on planktonic as well as on sessile Burkholderia cepacia complex cells.
Coenye, Tom, Nelis, Hans, Peeters, Elke
core   +1 more source

In-vitro susceptibility testing methods for the combination of ceftazidime-avibactam with aztreonam in metallobeta-lactamase producing organisms: Role of combination drugs in antibiotic resistance era

open access: yesJournal of antibiotics (Tokyo. 1968), 2022
Resistance in Gram-negative organisms has become one of the leading threats in recent years. Of the different mechanisms described in the literature, resistance due to beta-lactamases genes have been overcomed by the use of a beta-lactamase inhibitor in ...
Priya Sreenivasan   +6 more
semanticscholar   +1 more source

Ceftazidime: pharmacokinetics in young volunteers versus elderly patients and therapeutic efficacy with complicated urinary tract infections [PDF]

open access: yes, 1983
Thirty-six urological patients (21 male, 15 female) aged 21 to 83 years with complicated and/or hospital-acquired urinary tract infections due to sensitive bacteria were treated with ceftazidime intravenously with a daily dose of 2 g bd over 5 to 17 days.
Grobecker, H.   +2 more
core   +2 more sources

Primer relevamiento de marcadores de resistencia a antibióticos en Enterobacteriaceae en Cochabamba, Bolivia [PDF]

open access: yes, 2017
Se llevó a cabo un relevamiento molecular de la resistencia a antibióticos de importancia clínica en aislamientos recuperados en Cochabamba, Bolivia. Se estudiaron los genes codificantes de β-lactamasas de espectro extendido y de resistencia a quinolonas
Di Conza, José Alejandro   +3 more
core   +1 more source

Perbandingan Efektivitas Kombinasi Ceftazidime + Amikasin dan Ceftazidime sebagai Antibiotik Empiris Demam Neutropenia pada Keganasan

open access: yesSari Pediatri, 2016
Latar belakang. Terapi antibiotik empiris spektrum luas merupakan standar pengobatan demam neutropenia pada keganasan karena morbiditas dan mortalitas yang berhubungan dengan sepsis bakterial.
Agustinus William   +3 more
doaj   +1 more source

Poly(styrene-alt-maleic anhydride) Conjugated with Spermine: Synthesis, Antibacterial Activity and Antibiotic Susceptibility [PDF]

open access: yesعلوم و تکنولوژی پلیمر, 2018
Hypothesis: In the past decades, the increasing resistance to antibiotics among some nosocomial infection pathogens has been one of the largest challenges of human health. One of the ways to reduce antibiotic resistance in bacteria is the combination use
Jalil Javedani Bafekr   +3 more
doaj   +1 more source

A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime/avibactam in a case series of renal critically ill patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia.

open access: yesInternational Journal of Antimicrobial Agents, 2022
OBJECTIVES To describe the pharmacokinetic/pharmacodynamic (PK/PD) behaviour of continuous infusion (CI) ceftazidime/avibactam and the microbiological outcome in a case series of renal critically ill patients treated for documented carbapenem-resistant ...
Milo Gatti   +9 more
semanticscholar   +1 more source

Effect of β-lactamase inhibitors on in vitro activity of β-lactam antibiotics against Burkholderia cepacia complex species [PDF]

open access: yes, 2016
Background: Bacteria belonging to the Burkholderia cepacia complex (Bcc) are an important cause of chronic respiratory tract infections in cystic fibrosis patients. Intrinsic resistance to a wide range of antimicrobial agents, including a variety of beta-
Coenye, Tom, Everaert, Annelien
core   +2 more sources

Susceptibility of OXA-48-producing Enterobacterales to imipenem-relebactam, meropenem-vaborbactam and ceftazidime-avibactam.

open access: yesInternational Journal of Antimicrobial Agents, 2022
BACKGROUND Relebactam and vaborbactam are among the last β-lactamase inhibitors marketed. They were originally designed to inhibit the Ambler class A carbapenemase KPC.
R. Bonnin   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy